Brief pulses of ultrasound delivered to nerves near the kidney produced a clinically meaningful drop in blood pressure in people…
Home »
Obese people with pattern of later waking, peak activity later in day at higher risk of diabetes, cardiovascular disease
New research presented at this year’s European Congress on Obesity (held online, 10-13 May) shows that people living with obesity…
Living with HIV during a global pandemic
The impact of the coronavirus (COVID-19) pandemic has been profound for Delawareans living with HIV, according to a new report…
With 200,000 in 1 day, India skyrockets past 14M virus cases
India reported more than 200,000 new coronavirus cases Thursday, skyrocketing past 14 million overall as an intensifying outbreak puts a…
Lower COVID-19 rates seen in US states with higher adherence to mask wearing
A new state-by-state analysis shows a statistical association between high adherence to mask wearing and reduced rates of COVID-19 in…
Air pollution may affect severity and hospitalization in COVID-19 patients with respiratory disease
Patients who have preexisting respiratory conditions such as asthma or chronic obstructive pulmonary disease (COPD) and live in areas with…
More kids are being diagnosed with ADHD for borderline behaviors: Why that’s a concern
During my daughter’s challenging first year of school, we discovered how much effort it took her to sit and learn.…
Turning ‘human-centered’ vision for elderly care into reality with design
The Royal Commission into Aged Care left organizations that provide housing for aged care wondering how they will put its…
Removing care inequalities for teens and young adults with cancer
Adolescents and young adults (AYA) with cancer are often missing out on age-appropriate specialist care owing to a lack of…
FDA Approves Sarclisa (isatuximab-irfc) in Combination with Carfilzomib and Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma
PARIS, March 31, 2021 /PRNewswire/ — The U.S. Food and Drug Administration (FDA) has approved Sarclisa (isatuximab-irfc) in combination with…